BIM
IRMD icon

Bogle Investment Management’s iRadimed IRMD Stock Holding History

Bogle Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,387
Closed -$497K – 377
2018
Q3 		$497K Buy
+13,387
New +$361K 0.04% 240
2016
Q2 		– Sell
-38,171
Closed -$731K – 428
2016
Q1 		$731K Sell
38,171
-3,494
-8% -$66.9K 0.05% 296
2015
Q4 		$1.17M Buy
+41,665
New +$1.18M 0.08% 250

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Bogle Investment Management's IRMD Position: Q4 2018 in Review

Bogle Investment Management sold out of iRadimed (IRMD) in Q4 2018, closing a stake of 13,387 shares — an estimated $497K sold.

Bogle Investment Management first reported a position in IRMD in Q4 2015 and held it in 3 quarters. The position peaked at $1.17M in Q4 2015. 67 funds tracked by Wall St. Rank hold IRMD as of Q4 2018.

  • Bogle Investment Management reported no remaining iRadimed position as of Q4 2018 after selling out during the quarter.
  • Bogle Investment Management sold 13,387 iRadimed shares in Q4 2018, an estimated $497K.
  • Bogle Investment Management first reported a position in iRadimed in Q4 2015 and held it in 3 quarters.
  • Bogle Investment Management's iRadimed position peaked at $1.17M in Q4 2015.
  • 67 funds tracked by Wall St. Rank held iRadimed as of Q4 2018.

Based on Bogle Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.